Therapeutics insights
ICON’s therapeutic experts regularly contribute to industry publications on medical development challenges. Read more.
ICON's team of therapeutic experts contribute regularly to industry publications in addition to the creation of thought leadership content covering a broad spectrum of therapeutic areas.
-
Biosimilars
Insights and thought leadership from the experts at ICON's Centre for Biosimilar Drug Development.
-
Cardiovascular
Cardiovascular disease continues to be leading global cause of death, whilst COVID-19 further raises risk of death for those with underlying cardiovascular conditions.
-
Central Nervous System
Insights on the major trends in aging disorders and pain conditions in clinical trial designs and patient care.
-
Cell and Gene Therapies
Insights on accelerating study start-up and custom strategies based on lessons learned and best practices.
-
Endocrine and metabolic disorders
Global studies in endocrine & metabolic disorders is one of our strengths.
-
Hepatology
As a global leader in hepatology and MASH research, we delivers clinical expertise, experience, data and best practices to drive your program forward.
-
Pediatrics
Insights on clinical programmes involving neonates, children, adolescents, young adults, and pregnant women.
-
Rare and orphan diseases
Developing drugs for rare diseases involves complexities beyond those typically seen in large trials for more common conditions.
-
Respiratory
Expertise in respiratory clinical trials for drugs, devices, and drug-device combinations.
-
Women's health therapeutics
Specialist expertise and experience to address every stage of your women’s health program.
Public Health
Insights on disease prevention and control, health promotion and education, environmental health and health equity and social justice.
